Alpha Teknova (TKNO) vs Tilray Brands (TLRY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Alpha Teknova (TKNO) has outperformed Tilray Brands (TLRY) over the past year, gaining 66.2% versus a loss of 78.3%. Over five years, TKNO leads with a -62.3% price change compared with -96.4% for TLRY. Tilray Brands is the larger company by market cap ($530.5 million vs $453.1 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | TKNO | TLRY |
|---|---|---|
| Share price | $8.44 | $3.59 |
| Market cap | $453.13M | $530.54M |
| 1-day change | -3.10% | -3.36% |
| YTD return | +129.21% | -58.86% |
| 1-year return | +66.22% | -78.27% |
| 5-year return | -62.29% | -96.37% |
| Forward P/E | — | 20.22 |
| EPS (TTM) | $-0.31 | $-1.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.48 | $23.20 |
| 52-week low | $1.91 | $3.38 |
| Distance from 52-week high | -10.97% | -84.53% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +6.64% | +99.44% |
| Average volume | 230.99K | 4.07M |
| Shares outstanding | 53.69M | 147.78M |
| Employees | 158 | 3,595 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TKNO has outperformed TLRY by 144.5 percentage points over the past year.
About Alpha Teknova
TKNO stock →Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 158 employees
About Tilray Brands
TLRY stock →Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness.
Health Care · Medicinal Chemicals and Botanical Products · 3,595 employees
TKNO vs TLRY FAQ
Which is bigger, Alpha Teknova or Tilray Brands?
Tilray Brands (TLRY) is larger, with a market capitalization of $530.54M compared with $453.13M for Alpha Teknova (TKNO).
Which stock has performed better over the past year, TKNO or TLRY?
TKNO returned +66.22% over the past 12 months, compared with -78.27% for TLRY (price return, excluding dividends). Past performance does not predict future results.
Are Alpha Teknova and Tilray Brands in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: In Vitro & In Vivo Diagnostic Substances for Alpha Teknova and Medicinal Chemicals and Botanical Products for Tilray Brands.